Industry News Archive
View Industry News by Date
- IBS Market to Triple to $1.52bn by 2018 Tuesday 16 March
- OSI Board Rejects $3.5bn Astellas Offer Tuesday 16 March
- Pfizer Halts Lung Cancer Treatment Trial Tuesday 16 March
- Eli Lilly Snaps Up Underarm Testosterone Treatment Tuesday 16 March
- Chesapeake Develops Paperboard Packaging for Pharma Use Monday 15 March
- AstraZeneca's Cancer Drug Fails Trial Monday 15 March
- Ranbaxy and Takeda Settle Diabetes Drug Dispute Monday 15 March
- Sigma-Aldrich to Sell Pfizer's Bioactive Small Molecules Monday 15 March
- Watson's Long-Acting Prostate Cancer Agonist Approved Friday 12 March
- Roche and Biogen Ocrelizumab Trials Come to a Deadly Stop Friday 12 March
- AstraZeneca Strikes Torrent Generic Deal Friday 12 March
- Daiichi Sankyo Sees Ranbaxy Freedom as Key to Growth Friday 12 March
- ImmunoGen's Skin Cancer Treatment Wins Orphan Drug Status Thursday 11 March
- iToxFX Platform to Predict New Drug Safety Thursday 11 March
- Dainippon Schizophrenia Drug Set for Review in US Thursday 11 March
- Experts Call for Vascular-Friendly Migraine Drug Thursday 11 March
- Good Results for Nektar's Ovarian Cancer Drug Wednesday 10 March
- South Korean Team Develops Killer Flu Antibodies Wednesday 10 March
- FDA Approves Botox as Post-Stroke Joint Treatment Wednesday 10 March
- GSK and Cellzome Announce Inflammatory Alliance Deal Wednesday 10 March
- Rexahn's Anti-Cancer Compound Wins Japanese Patent Tuesday 09 March
- Phase B of Novavax's Mexican Flu Vaccine Trial Begins Tuesday 09 March
- Sanofi-Aventis's Prostate Cancer Drug Passes Trial Tuesday 09 March
- US Researchers to Develop Bioterror Antidote Tuesday 09 March
- CombinatoRx's Chronic Painkiller Gets FDA Approval Monday 08 March
- Good Results for Investigational Anticoagulant Apixaban Monday 08 March
- Isis Initiates Neurodegenerative Drug Trials Monday 08 March
- EU Experts Call for Better Migraine Management Monday 08 March
- FDA and EPA Simplify Orphan Drug Development Process Friday 05 March
- Abbott and Enanta Initiate Phase II HepatitisTrials Friday 05 March
- Nanotechnology Market to Soar to 2014 Friday 05 March
- US Court Upholds Shire's ADHD Drug Exclusivity Friday 05 March
- FDA Approves Novo Nordisk's Growth Hormone Treatment Thursday 04 March
- Sanofi's Advanced Prostate Cancer Drug Looks Promising Thursday 04 March
- Abbott and GSK Collaborate on Skin Cancer Test Thursday 04 March
- Cleveland Offers Army Radiation Antidote Thursday 04 March
- Production Starts at China-Biotics Facility in Shanghai Wednesday 03 March
- Astellas to Take Bid to OSI Shareholders Wednesday 03 March
- FDA Approves First Prostate Generic Wednesday 03 March
- New Guidance to Boost Cell-Based Vaccine Development Wednesday 03 March
- FDA and NIH to Speed Up Biomedical Innovation Tuesday 02 March
- Evotec to Assist Cubist's Antibacterial Targets for Drug Development Tuesday 02 March
- Regulus and GlaxoSmithKline Collaborate for HCV Tuesday 02 March
- PPD’s Research Facility Opens in Ireland Tuesday 02 March
- Merck in $7.2bn Deal for Biotech Maker Millipore Monday 01 March
- FDA Approves New Gaucher Therapy Monday 01 March
- Astrazeneca's Brilinta Expected to Win Out in Coronary Market Monday 01 March
- Sunesis to Begin Phase III AML Trials Monday 01 March
- Germans Prefer Low-Cost Drugs Over Brand Friday 26 February
- Genentech and UCSF Team Up on Drug Development Friday 26 February
- VEGF Trap-Eye Shows Positive Results Friday 26 February
- Daiichi Sankyo Enters Japanese Generic Market Friday 26 February
- Karus Adds HDAC-6 Inhibitors to Development Pipeline Thursday 25 February
- Trana to Develop tRNA Identification-Based Diagnostic Thursday 25 February
- Broad Pneumococcal Vaccine Approved in the US Thursday 25 February
- Sanofi-Aventis's Breast Cancer Drug to Earn $1.7bn by 2018 Thursday 25 February
- Aptuit Develops Proprietary Production Screen Wednesday 24 February
- Amylin and Takeda to Tackle Obesity Wednesday 24 February
- NCC and Pfizer Treat Haemophilia in Developing World Wednesday 24 February
- FDA Concerned Over HIV Drugs Heart Risk Wednesday 24 February
- Seasonal Flu Vaccine Should Have H1N1 Strain, Says WHO Tuesday 23 February
- Inhaled Cystic Fibrosis Antibiotic Provides Breakthrough Tuesday 23 February
- First Subcutaneous Biosimilar Approved for Renal Patients Tuesday 23 February
- AstraZeneca Settles UK Tax Dispute Tuesday 23 February
- US Approves Novartis Meningitis Drug Monday 22 February
- US-Oslo Alliance Strengthens European Bioscience Monday 22 February
- US Companies Rush to Find Diabetes Cure Monday 22 February
- EU Clears Path for GSK's Cancer Medicines Monday 22 February
- Leukaemia Drug Rituxan Approved in US Friday 19 February
- FDA Sets Priority Status for Tasigna Review Friday 19 February
- FDA Cracks Down on Dangerous Asthma Drugs Friday 19 February
- Targeted Cancer Drug Market to Reach $51bn Friday 19 February
- Sanofi Pasteur Recalls More Influenza Vaccines Thursday 18 February
- Genotype Screening Finds Cervical Cancer Earlier Thursday 18 February
- Roche and Merck Collaborate on Gene Mutation Test Thursday 18 February
- GSK's President Wins Woman of the Year Award Thursday 18 February
- Safety Plan for Potentially Dangerous Cancer Drugs Wednesday 17 February
- AstraZeneca Prescription Plan Saves Millions Wednesday 17 February
- Quark's Kidney Transplant Drug Granted Orphan Status Wednesday 17 February
- US Orthopaedic Biomaterials Market to Reach $6.3bn by 2016 Wednesday 17 February
- EU and Swissmedic Agree to Share H1N1 Info Tuesday 16 February
- Vital Diabetes Drugs Arrive in Haiti Tuesday 16 February
- Abbot Completes €4.5bn Solvay Deal Tuesday 16 February
- AstraZeneca Leaps for Rigel's Arthritis Drug Tuesday 16 February
- Shire Presents Positive Gaucher Trial Data Monday 15 February
- UK Tentatively Backs Diabetes Drug Victoza Monday 15 February
- Proteonomix Forms Stem Cell Institute Monday 15 February
- Mississippi Bans Pseudoephedrine in OTC Drugs Monday 15 February
- Hi-Tech Performance Drug Tests Well Friday 12 February
- FDA Approves Improved HIV Tablets Friday 12 February
- NewLink Gets Go-Ahead for Pancreatic Cancer Trials Friday 12 February
- EU Clears Abbot's Solvay Buyout Friday 12 February
- Catalysis Receives Gates Grant for TB Biomarker Thursday 11 February
- Simcere to Market Flu Drug in China Thursday 11 February
- Good Results for Roche's Type 2 Diabetes Drug Thursday 11 February
- Nontraditional Players Essential for Pharmaceutical Survival Thursday 11 February
- Amgen Announces Positive Prostate Cancer Drug Trials Wednesday 10 February
- UK Company to Begin First Stroke Stem Cell Trial Wednesday 10 February
- UK Health Body Rejects Expensive Cancer Drug Wednesday 10 February
- FDA Approves Pre-emptive Heart Attack Drug Wednesday 10 February
- FDA Approves Hypertension Generics Tuesday 09 February
- Addex Pain Drug Shows Broad Effects Tuesday 09 February
- Vantia’s Nocturia Candidate Enters Stage Two Trials Tuesday 09 February
- Novartis Moves for Potent Hepatitis C Treatment Tuesday 09 February
- BioMarin to Acquire LEAD Therapeutics Monday 08 February
- Novavax Stops Flu Vaccine Collaboration Monday 08 February
- SWIFT Haemophilia Drug Trials Begin Monday 08 February
- Teva to Settle Drug Price Fixing Claims Monday 08 February
- Avexa Announces Positive HIV Therapy Trials Friday 05 February
- Shire Applies For Fabry Drug Licensing in US Friday 05 February
- Qiagen and Pfizer to Develop Brain Tumour Diagnostic Friday 05 February
- GSK Launches Special Disease Unit Friday 05 February
- Biosimilars Market Driven by Pharma Spending Cuts, Study Says Thursday 04 February
- Daiichi Sankyo Initiates VTE Trials Thursday 04 February
- Teva Files Application for New Neutropenia Drug Thursday 04 February
- Ipsen and Debiopharm Launch New Cancer Drug in France Thursday 04 February
- New Once-Daily Parkinson's Tablet Launched Wednesday 03 February
- US Approves Treatment for Debilitating Hand Disease Wednesday 03 February
- Biomedical Industry Key to California's Growth Wednesday 03 February
- Hypertension Drug Market Bleak to 2018 Wednesday 03 February
- Evotec and Vifor Develop Anaemia Partnership Tuesday 02 February
- New Collaboration to Protect Children Against Pneumonia Tuesday 02 February
- HIV Drug Causes Serious Liver Problems Tuesday 02 February
- FDA Requests $4bn to Transform Safety and Push Science Tuesday 02 February
- Sanofi-Aventis Extends Chinese Footprint Monday 01 February
- Lamictal Use Extended to Treat Generalised Seizures Monday 01 February
- Watson Moves for Eden's Biodesigns Monday 01 February
- FDA Approves New Breast Cancer Combo Monday 01 February
- FDA Approves Lupin's Heart Drug Friday 29 January
- ChemoCentryx Initiates Novel Autoimmune Trials Friday 29 January
- Conatus Trials Triple-Combo Hepatitis C Treatment Friday 29 January
- EU Approves Merck's Fertility Treatment Friday 29 January
- Teva Attempts to Launch Generic Version of Gilead Drug Thursday 28 January
- Pacgen Forms Tie with New Summit to Target Chinese Market Thursday 28 January
- Rotavirus Vaccines Can Save Two Million Lives, Studies Show Thursday 28 January
- Pfizer Bio VP Pits IT as the Next Big Thing in Pharma Thursday 28 January
- Trials Start on Renal Cancer Drug Wednesday 27 January
- UK Under Pressure to Allow Heart Drug on NHS Wednesday 27 January
- Threshold to Continue Trialling Tumour Drug Wednesday 27 January
- Novartis Names New CEO Wednesday 27 January
- Biogen Kicks Off Haemophilia B Trials Tuesday 26 January
- Abbott Seeking Approval for Rapid HIV Test Tuesday 26 January
- EMEA Reviewing Lipase Deficiency Treatment Tuesday 26 January
- US Approves New Type 2 Diabetes Drug Tuesday 26 January
- Cantab to Focus on Biosuperior Research Monday 25 January
- Good Results for Pancreatic Cancer Drug Sutent Monday 25 January
- Pharma Rises After US Health Reform Setback Monday 25 January
- New MS Drug to Get Patients on Their Feet Monday 25 January
- Inspire Drug for Dry Eye Disease Fails Late-Stage Trial Friday 22 January
- Roche Drug Helps Elderly Be Cancer-Free for Longer Friday 22 January
- Leading Obesity Drug Suspended in UK Friday 22 January
- Latest Trials Show Hope for MS Drug Friday 22 January
- Good Early Results for Sangamo's HIV Drug Thursday 21 January
- Japan Approves First Psoriasis Biologic Thursday 21 January
- Cumberland Donates Caldolor to Haitian Relief Effort Thursday 21 January
- GSK to Tackle Third World Diseases Thursday 21 January
- Novartis Snaps Up Chiasma's Small Molecule Enhancer Wednesday 20 January
- Boehringer Ingelheim and Priaxon to Research New Cancer Drugs Wednesday 20 January
- Diabetes Drug Victoza Approved in Japan Wednesday 20 January
- GSK to Open up Malaria Research Wednesday 20 January
- MorphoSys Enrolls First Patient in Arthritis Trial Tuesday 19 January
- Study Finds Need for Dose Variation in Psoriasis Drugs Tuesday 19 January
- AstraZeneca and Dako Join to Develop Cancer Treatments Tuesday 19 January
- Healthcare Fraud Costs $260bn Each Year Tuesday 19 January
- Multi-Million Kickback Suit Filed Against J&J Monday 18 January
- EMA Waiver Paves Way for StemEx Leukaemia Study Monday 18 January
- J&J Issues Major OTC Drug Recall Monday 18 January
- Novartis Sends Aid to Haiti Monday 18 January
- Pharma Companies Join Haiti Aid Effort Friday 15 January
- UK Pushes MS Stem Cell Research Friday 15 January
- Acceleron Announces Exciting New Drug Candidates Friday 15 January
- Octapharma's Wilate Plasma Given Orphan Drug Status Friday 15 January
- FDA Makes Drug Approval More Transparent Thursday 14 January
- 3D Structures Could Lead to Improved Drugs Thursday 14 January
- GSK Agrees to Cut Flu Vaccine Orders Thursday 14 January
- Biogen Snaps Up Trillium's Biologic Platform Thursday 14 January
- Sorrento Springs for Scripps MRSA Technology Wednesday 13 January
- Amarin's Cardio Drug Moves to Phase III Trials Wednesday 13 January
- FDA and Biovista to Collaborate on Medication Safety Wednesday 13 January
- Parkinson's Drug Azilect Launched in France Wednesday 13 January
- Pharmaron Acquires Bridge Laboratories China Tuesday 12 January
- BioMarin Initiates Muscular Dystrophy Drug Trials Tuesday 12 January
- FDA Approves Risky New Arthritis Drug Tuesday 12 January
- Medivation Kicks Off Prostate Cancer Trials Tuesday 12 January
- US and Germany Slash H1N1 Vaccine Orders Monday 11 January
- Novartis Launches Schizophrenia Treatment Fanapt Monday 11 January
- EU Opens Official Lundbeck Investigation Monday 11 January
- India Stays Decision to Block Natco's Cancer Drug Monday 11 January
- NexBio Starts Flu Drug Trial in Mexico and US Friday 08 January
- First Phase of Huntington's Drug Trial Begins in EU Friday 08 January
- US Psychiatric Patients Likely to be Given Combination of Drugs Friday 08 January
- US Has Made No Decision about Selling H1N1 Vaccines Friday 08 January
- Ensemble and Pfizer to Develop Novel Drug Candidates Thursday 07 January
- Eisai Acquires AkaRx and Blood Drug Rights Thursday 07 January
- Canada Lends Swine Flu Vaccine to Mexico Thursday 07 January
- AstraZeneca and Teva Settle Gastro Generic Dispute Thursday 07 January
- UK Rejects Leukaemia Drugs as Expensive and Unproven Wednesday 06 January
- UK Clears Path for More Generic Medicines Wednesday 06 January
- EU Approves Rare LEMS Disease Drug Wednesday 06 January
- EnVivo Schizophrenia Drug Enters Phase 2 Trials Wednesday 06 January
- Proximagen Moves for Minster Pharmaceuticals Tuesday 05 January
- Medicines Co Sues Teva and Pliva over Angiomax Generic Tuesday 05 January
- Japan's Dainippon Submits New Schizophrenia Drug to FDA Tuesday 05 January
- EU Approves Pfizer's Injectable PAH Treatment Tuesday 05 January
- FDA to Review Seizure Treatment Retigabine Monday 04 January
- Novartis Eyes up $39.3bn Alcon Deal Monday 04 January
- Evolva and Roche Enter Oncology Research Collaboration Monday 04 January
- France to Sell Off Surplus Swine Flu Vaccines Monday 04 January
- FDA Approves High-Dose Flu Vaccine for Seniors Thursday 24 December
- Merck Discontinues Atherosclerosis Drug Programme Thursday 24 December
- Lilly and Kowa to Co-Promote Cholesterol Drug in US Thursday 24 December
- Amgen calls Victory in Roche Anaemia Drug Dispute Wednesday 23 December
- Packaging Error Forces P&G to Recall Medicine Wednesday 23 December
- Eli Lilly works with Applied NeuroSolutions on Alzheimer's Treatment Wednesday 23 December
- Placon Launches Eco-Friendly Pharma Packaging Tuesday 22 December
- Positive Results for Medicago's Avian Flu Jab Tuesday 22 December
- Daiichi Sankyo Launches Ranbaxy's Antihypertensive in Africa Monday 21 December
- Orphan Drug Designation for Pixantrone in Europe Monday 21 December
- WHO Sanctions All Novartis Flu Vaccines for Developing World Monday 21 December
- Trials Begin on Innovative Ovarian Cancer Compound Friday 18 December
- FDA Approves Long-Acting Schizophrenia Drug Friday 18 December
- GSK and NanoBio to Launch New Cold Sore Treatment Thursday 17 December
- Sanofi Partnership to Develop Staphylococcus Vaccine Thursday 17 December
- Merck Serono Collaboration to Advance MS Treatments Thursday 17 December
- FDA Approves Alzheimer's Generic Wednesday 16 December
- Takeda and Pfizer to Co-Promote Actos in China Wednesday 16 December
- Addex Stops Migraine Study Due to Liver Problems Tuesday 15 December
- Nine Deaths Halt Elan's High-Dose Alzheimer's Trial Tuesday 15 December
- FDA Allows Roche to Resume Avastin Trial Monday 14 December
- US Must Spend More on Vaccine Safety, Report Says Monday 14 December
- HIV Prevention Gel Fails Trial Monday 14 December
- Oncothyreon Shares Up on News of Lung Cancer Trial Friday 11 December
- Targacept Starts Schizophrenia Drug Trial Friday 11 December
- Roche Sees Positive Results in Arthritis Drug Friday 11 December
- Asthma Sufferers Could be Helped by Cancer Drug Thursday 10 December
- GSK Expands Heart Drug Trials Thursday 10 December
- Roche Cancer Trials Show Positive Results Thursday 10 December
- Major Child Cancer Study to Begin in UK Thursday 10 December
- Micromet's Leukaemia Drug Shows Positive Results Wednesday 09 December
- Bionomics to Launch Anti-Cancer Drug Trial in Australia Wednesday 09 December
- GE and Covidien MRI Drugs May Pose Higher Risk, Advisers Warn Wednesday 09 December
- Effectiveness of Flu Antiviral Tamiflu in Question Wednesday 09 December
- FDA Approves New Sustained Release Drug Applications Tuesday 08 December
- First Treatment Approved for von Willebrand Disease Tuesday 08 December
- Diabetes Gene Linked to Childhood Obesity Tuesday 08 December
- South Korea Offers Swine Flu Aid to the North Tuesday 08 December
- J&J Novel Anticoagulant Tests Well in Trials Monday 07 December
- US Approves Major Depression Add-On Treatment Monday 07 December
- Lilly's Adolescent Bipolar Treatment Approved Monday 07 December
- BiondVax Close to Universal Flu Vaccine Monday 07 December
- Good Results for DermaGen's New Skin Treatment Friday 04 December
- Takeda Announces Strategic Push into Brazil Friday 04 December
- Green Tea Chemical Could Cure Brain Disorders Friday 04 December
- New Database to Boost European Cancer Research Friday 04 December
- US Fast Tracks New Multiple Myeloma Drug Thursday 03 December
- Hereditary Angioedema Treatment Approved in US Thursday 03 December
- Cephalon Files Patent Lawsuit Against Teva Thursday 03 December
- Good Results from Novavax's Mexican Flu Vaccine Trials Thursday 03 December
- FDA Approves Over-the–Counter Heartburn Drug Wednesday 02 December
- J&J Seeks Approval for New Chronic Pain Treatment Wednesday 02 December
- WHO Prequalifies GSK's Pandemic Flu Drug Wednesday 02 December
- Transgene's Lung Cancer Therapy Fast-Tracked Wednesday 02 December
- Patients Enrolled for Pivotal Bladder Cancer Trials Tuesday 01 December
- FDA Approves New LEMS Treatment Tuesday 01 December
- FDA Rejects New Cladribine Indication Tuesday 01 December
- Eli Lilly's Anxiety Drug Wins US Approval Tuesday 01 December
- Seasonal Flu Drug Agriflu Approved in US Monday 30 November
- EU Approves Anti-Arrhythmic Multaq Monday 30 November
- Innovation Pass to Get New Drugs to UK Patients Monday 30 November
- New Tumour Compounds Show Remarkable Results Monday 30 November
- Ranbaxy Launches Herpes Generic in US Friday 27 November
- Sun Pharma's ADHD Generic Tentatively Approved in US Friday 27 November
- Powerful New Hay Fever Drug Available in EU Friday 27 November
- Cardio Drug Micardis Wins EU Nod Friday 27 November
- Drug-Resistant Bacterial Infection on the Rise in US Friday 27 November
- Idera and Merck Extend Vaccine Adjuvant Alliance Thursday 26 November
- HGS Seeking Approval for New Hepatitis C Treatment Thursday 26 November
- FDA Approves Treatment for Resistant HIV Patients Thursday 26 November
- Chronic Leukaemia Treatment Granted EU Orphan Status Thursday 26 November
- Shire Submits New Gaucher Treatment to EU Wednesday 25 November
- Ipsen Initiates Novel Cancer Inhibitor Trials Wednesday 25 November
- Novartis Moves for Incyte's Cancer Therapies Wednesday 25 November
- Gilead and GSK Enter Asian Hepatitis Market Wednesday 25 November
- New Once-Daily Launched for Parkinsons Tuesday 24 November
- GSK Announces Flu Vaccine Ready for All Ages Tuesday 24 November
- Merck Serono Extends Chinese Footprint Tuesday 24 November
- Researchers Optimistic Over New Cancer Pain Drug Tuesday 24 November
- Hungary Declares Swine Flu a National Epidemic Monday 23 November
- Abilify Approved for Autism Behaviours in Children Monday 23 November
- Pfizer's Geodon Approved for Bipolar Disorder Monday 23 November
- Positive Results for Genta's Leading Oncology Drug Monday 23 November
- Morphine Linked to Spread of Cancer Monday 23 November
- EU Approves Advanced Gastric Cancer Treatment Friday 20 November
- Adamas Expands Triple-Combo Flu Trial Friday 20 November
- New Hope for People with Cat Allergies Friday 20 November
- Operation Pangea Cracks Down on Illegal Pharma Sites Friday 20 November
- AstraZeneca Submits New Heart Drug Application Thursday 19 November
- Jennerex and Lee's to Develop New Cancer Drug in Asia Thursday 19 November
- US Researchers Target New Tumour Treatment Thursday 19 November
- Drug Industry Positive About 2010 Thursday 19 November
- Schizophrenia Drug Shows Fewer Side Effects Wednesday 18 November
- ALK Launches Largest-Ever Child Asthma Trial Wednesday 18 November
- FDA Approves Chilli Treatment for Shingles Pain Wednesday 18 November
- Cancer Pain Market to Reach $3.7bn by 2018 Wednesday 18 November
- US Opts for Freeze-Dried Smallpox Vaccine Tuesday 17 November
- FDA Approves Fifth Swine Flu Vaccine Tuesday 17 November
- Novavax Enrols Patients for Mexican Flu Trial Tuesday 17 November
- GSK Announces Deal for Potential Nicotine Vaccination Tuesday 17 November
- BioInvent and Daiichi Sankyo Target Multiple Antibodies Monday 16 November
- Bristol-Myers Drops Mead to Focus on Biopharma Monday 16 November
- Promising Results for New Addex Heartburn Drug Monday 16 November
- Shanghai Orders Sinovac Hepatitis Vaccine Monday 16 November
- Allergy Drug Also Reduces Nasal Congestion Friday 13 November
- Record Number of Drugs Being Developed for Women Friday 13 November
- Dementia Drugs Contribute to Patient Deaths, Report Shows Friday 13 November
- WHO Pushes Early Antiviral Treatment for H1N1 Friday 13 November
- Novartis Launches Prevacid 24HR OTC Across US Thursday 12 November
- Merck and Isofol Sign Agreement for Cancer Drug Thursday 12 November
- Sanofi Confirms Safety of H1N1 Vaccine Thursday 12 November
- Pfizer Skewed Positive Data from Neurontin Trials, Researchers Say Thursday 12 November
- Bristol-Myers and Alder to Research New Arthritis Biologic Wednesday 11 November
- Teva Wins Right to Market Heartburn Generic Wednesday 11 November
- Novartis Three-in-One Blood Pressure Drug Approved in EU Wednesday 11 November
- New Treatment Combo Reduces Breast Cancer Recurrence Wednesday 11 November
- Pharma Packaging With High Temperature Resistance Launched Tuesday 10 November
- Astellas Swoops for Promising IBS Treatment Tuesday 10 November
- Novel Epilepsy Treatment Zebinix Launched in the UK Tuesday 10 November
- GSK to Donate H1N1 Vaccine to Developing World Tuesday 10 November
- New Lou Gehrig's Treatment Wins Orphan Status Monday 09 November
- US Approves New Lymphoma Treatment Romidepsin Monday 09 November
- Destiny Antibiotic Finds New Ways to Kill Bacteria Monday 09 November
- GSK Combines Seasonal and Pandemic Flu Shots Monday 09 November
- Pfizer Extends Autoimmune Collaboration with Ligand Friday 06 November
- Abraxane Wins Orphan Drug Designation Friday 06 November
- Novexel Begins Advanced Skin Infection Treatment Trials Friday 06 November
- Lymphoma Drug Could Fight Deadly Bone Cancer Friday 06 November
- Inspire Completes Patient Enrollment in Late-Stage Trials Thursday 05 November
- Novartis Gets German Approval for Celtura Flu Vaccine Thursday 05 November
- New Agreement Targets Obesity Thursday 05 November
- CONCERTA Tests Prove Productive Thursday 05 November
- New Research Raises Concern About Use of Antibiotics During Pregnancy Wednesday 04 November
- Pazopanib Included in NCCN Oncology Guidelines Wednesday 04 November
- Seasonal Influenza Vaccine Makes Progress Wednesday 04 November
- World's Largest Malaria Vaccine Trial Underway Across Africa Wednesday 04 November
- StemEx Could Provide Bone Marrow Alternative Tuesday 03 November
- Gilead and GSK to Collaborate on Blood Pressure Study Tuesday 03 November
- Groundbreaking Lupus Treatment Makes Progress Tuesday 03 November
- Novartis to Invest $1bn in Chinese R&D Tuesday 03 November
- Procter & Gamble Warned Over Illegal Flu Medicines Monday 02 November
- Byetta Awarded First-Line Diabetes Status in US Monday 02 November
- Lilly CEO Criticises Lack of Biopharma Innovation Monday 02 November
- Amylin and Takeda to Take on Obesity Monday 02 November
- Coding to Secure Pharma Labelling Friday 30 October
- Eli Lilly Opens New Biotech Centre Friday 30 October
- New Partnership to Commercialise Caldolor Down Under Friday 30 October
- Sanofi-Aventis and Micromet to Develop New Tumour Antibody Friday 30 October
- UK Recommends Topotecan for Cervical Cancer Thursday 29 October
- FDA Gives Tentative Backing to Transcept's Intermezzo Thursday 29 October
- Abbott Applies for New Humira Indication in Japan Thursday 29 October
- Novartis Flu Vaccine on Track for the US Thursday 29 October
- EU Approves First CAPS Treatment Wednesday 28 October
- Huxley Acquisition Lands Biomarin New LEMS Treatment Wednesday 28 October
- NeoPharm Submits Frontline Pancreatic Cancer Treatment Wednesday 28 October
- AstraZeneca Withdraws Approval Request for Zactima Wednesday 28 October
- Chronic Leukaemia Treatment Azerra Approved in US Tuesday 27 October
- Shire's Vyvanse Five-Year Exclusivity Stands Tuesday 27 October
- Peramivir to be Used for Special Swine Flu Cases Tuesday 27 October
- French Scientists Unlock Novel Gene-Silencing Protein Tuesday 27 October
- Repligen Licenses Spinal Muscular Atrophy Compounds Monday 26 October
- Arena's Lorcaserin Trial Shows Positive Results Monday 26 October
- Ceplene's Cost Effectiveness Proved for UK AML Patients Monday 26 October
- Singapore’s Drop in Industrial Production Linked to its Pharmaceutical Sector Monday 26 October
- Corn Protein Could Replace Pill Coatings Friday 23 October
- Bayer and Onyx Advance Thyroid Cancer Drug Trials Friday 23 October
- First Myelofibrosis Treatment Trial Ends Friday 23 October
- EU Approves Novartis 3-in-1 Blood Pressure Treatment Friday 23 October
- GE and Lilly Collaboration Unlocks New Biomarkers Thursday 22 October
- Novax and Xcellerex Accelerate Flu Vaccine Thursday 22 October
- Roche Kicks Off Enhanzed Cancer Drug Trial Thursday 22 October
- US Pharma Companies Pay Off Medicaid Fraud Claims Thursday 22 October
- UK Rolls Out Swine Flu Vaccinations Wednesday 21 October
- Antibiotic-Resistant Diseases Cost the US Billions Each Year Wednesday 21 October
- Human Genome and GSK Announce Positive Lupus Study Results Wednesday 21 October
- Kinaxo and Roche Collaborate to Research Innovative New Biomarkers Wednesday 21 October
- GSK's Children's Flu Vaccine Approved in US Tuesday 20 October
- FDA Approves New Kidney Cancer Treatment Tuesday 20 October
- Novavax Launches New Swine Flu Study in Mexico Tuesday 20 October
- New Leukaemia Drug Excels in Head-to-Head Trial Tuesday 20 October
- US Approval for GSK's Cervical Cancer Vaccine Monday 19 October
- FDA Approves Crestor for Paediatric Cholesterol Monday 19 October
- France Biotech to Invest State Funds in Vaccine Research Monday 19 October
- Biogen and Biovitrum to Take Haemophilia B Therapy to Trials Monday 19 October
- Inovio Kicks off New HIV DNA Vaccine Trials Friday 16 October
- Pfizer Completes Wyeth Takeover Friday 16 October
- Kinaxo and Bayer Vital to Search for New Cancer Biomarkers Friday 16 October
- FDA Backs Accorda's Improved Mobility Treatment for MS Friday 16 October
- Pfizer Receives US and Canadian Go-Ahead for Wyeth Acquisition Thursday 15 October
- Bio-Matrix to Aggressively Pursue Stem Cell Funding Thursday 15 October
- Boehringer Ingelheim's Parkinson's Once-Daily Approved in the EU Thursday 15 October
- Sanofi Pasteur's Flu Vaccine Tests Well in Children Thursday 15 October
- FDA Authorises Emergency Use of Diatherix Swine Flu Test Wednesday 14 October
- OPKO to Acquire Schering-Plough's Nausea Programme Wednesday 14 October
- Compugen and Bayer Schering Set Sights on New Tumour Target Wednesday 14 October
- AMT's Muscular Dystrophy Treatment Granted EU Orphan Designation Wednesday 14 October
- New 3D Drug Imaging Brings Controlled Release Breakthrough Tuesday 13 October
- Raptor Announces Positive Results for New Liver Disease Treatment Tuesday 13 October
- Onyx Breaks into Haematological Market with Proteolix Acquisition Tuesday 13 October
- Novartis Snaps Up Rights for Important New Schizophrenia Therapy Tuesday 13 October
- FDA Approves First Treatment for Hereditary Angioedema Monday 12 October
- Sinclair Pharma Moves for Solvay's Burn Treatments Monday 12 October
- BioAlliance to Begin New Pain Drug Trials in France Monday 12 October
- Intralytix Wins Army Contract to Develop Shigella Treatment Monday 12 October
- Grunenthal to Supply Labopharm's Pain Drugs in Europe Friday 09 October
- Hospira Strikes Deal for South Korean Biogenerics Friday 09 October
- AC Immune and Bayer Schering to collaborate on Alzheimer's Vaccine Friday 09 October
- US Extends Avanir's Zenvia Patent Friday 09 October
- Sanofi's Humenza and Panenza Flu Vaccines Succeed in Trials Thursday 08 October
- Novartis Swoops for Promising New Antibiotic Thursday 08 October
- Shire Study Compares Phosphate Binders in Kidney Disease Thursday 08 October
- FDA Approves APP's Migraine Treatment Thursday 08 October
- EU Investigators Raid Pharma Giants Wednesday 07 October
- India's Lupin and Salix Join for New Rifaximin Combo Wednesday 07 October
- GSK Forms Paediatric Vaccine Alliance in China Wednesday 07 October
- Diamyd Diabetes Vaccine Trial Set to Begin Wednesday 07 October
- FDA Committee Backs GSK's Votrient Kidney Cancer Treatment Tuesday 06 October
- Novartis Ships 27 Million Seasonal Flu Doses to the US Tuesday 06 October
- UCB's RA Treatment Cimzia Granted EU Approval Tuesday 06 October
- Depomed Announces Top Results for New Pain Drug Tuesday 06 October
- EU Recommends Third Flu Vaccine for Authorisation Monday 05 October
- UK Recommends Hycamtin for Relapsed Lung Cancer Monday 05 October
- Genentech's Lucentis Eye Drug Shows Good Clinical Results Monday 05 October
- Japan Launches First Biosimilar Somatropin Monday 05 October
- Sanofi Flu Vaccine Shows Success After One Dose Friday 02 October
- GSK Flu Pandemic Vaccine Receives EU Approval Friday 02 October
- Sanofi-Aventis to Acquire French Ocular Experts Fovea Friday 02 October
- EU Ingredient Companies to Merge Friday 02 October
- Novartis Sees Good Clinical Results for Tumour Treatment Sandostatin Friday 02 October
- Merck Submits New Oral MS Treatment for US Approval Thursday 01 October
- Sanofi-Aventis Moves for Merrimack's Promising New Antibody Thursday 01 October
- New CTI Oesophagus Cancer Trial Shows Good Results Thursday 01 October
- Mylan’s Parkinsons Generics Approved in the US Thursday 01 October
- CTI Requests EU Orphan Drug Designation for Pixantrone Wednesday 30 September
- AstraZeneca’s Seroquel Approved in EU to Treat All Bipolar Phases Wednesday 30 September
- Abbott and Eisai Seek Japanese Approval for Crohn's Disease Treatment Wednesday 30 September
- Taiwan Institute Joins Lilly TB Drug Discovery Initiative Wednesday 30 September
- Abbott to Acquire Solvay Pharmaceuticals Tuesday 29 September
- Chronic Leukaemia Treatment Rituximab Available in UK Tuesday 29 September
- UCB and AstraZeneca Form Brazilian Pharma Partnership Tuesday 29 September
- UK Probes Cancer Vaccine Death Tuesday 29 September
- US Approves New Psoriasis Drug Monday 28 September
- First Peripheral T-cell Lymphoma Treatment Approved Monday 28 September
- Novartis Flu Vaccine Cleared for EU Approval Monday 28 September
- Pfizer to Continue Japanese Collaboration Monday 28 September
- FDA to Review Cephalon for Excessive Sleepiness Friday 25 September
- New Study Confirms Azilect Slows Parkinson's Disease Friday 25 September
- UK Recommends Permetrexed as First Choice Lung Cancer Treatment Friday 25 September
- US Court Backs Eli Lilly's Evista Patents Friday 25 September
- UK Approves Breakthrough Psoriasis Treatment Stelara Thursday 24 September
- Plexxikon Melanoma Treatment Shows Good Phase I Results Thursday 24 September
- US Orders More Doses of Sanofi H1N1 Vaccine Thursday 24 September
- Exciting Trial Shows HIV Vaccine Cuts Infection Thursday 24 September
- UK Introduces Measures to Boost Vaccination Equality Wednesday 23 September
- UK Recommends Sunitinib for Gastrointestinal Tumours Wednesday 23 September
- Novartis Gets EU Go-Ahead for Ebewe Takeover Wednesday 23 September
- EU Plans First International Biobank Wednesday 23 September
- US Lifts Temporary Suspension of Children’s Hib Vaccine Tuesday 22 September
- Neuralstem Given Go-Ahead for First ALS Stem Cell Trial Tuesday 22 September
- Vectibix Shows Good Results Against Colorectal Cancer Tuesday 22 September
- AstraZeneca and Nektar to Collaborate on Drug Development Tuesday 22 September
- Wyeth and Ambrx Ally to Develop Protein Drugs Monday 21 September
- Australia Approves CSL Swine Flu Vaccine Monday 21 September
- Glenmark Anti-Hypertension Tablets Approved in US Monday 21 September
- Ipsen’s Cosmetic Muscle Relaxant Azzalure Approved in Spain Monday 21 September
- US Senate Votes to Improve Clinical Trial Access Friday 18 September
- Novartis New Blood Pressure Drug Valturna Approved in US Friday 18 September
- Genentech Study Shows Rixutan Reduces Lymphoma Progression Friday 18 September
- Teva Moves For Rexahn's Novel Anti-Cancer Compound Friday 18 September
- Matrix’s Combo HIV Treatment Approved in the US Thursday 17 September
- GSK Memo Reveals Scientists Withheld Paxil's Heart Risk Thursday 17 September
- EU Calls for New Cures to Treat Multidrug-Resistant Bacteria Thursday 17 September
- New Study Shows Valdoxan is Superior to Prozac Thursday 17 September
- FDA Approval Signals Start of Flu Vaccine Distribution in US Wednesday 16 September
- Advanced Life Sciences' Restanza Could Treat Plague and Anthrax Wednesday 16 September
- Novartis Investigational COPD Drug Increases Lung Function Wednesday 16 September
- Bristol-Myers Sells Asia Pharma Rights to Taisho Wednesday 16 September
- Saphris Shown to Reduce Chance of Schizophrenia Relapse Tuesday 15 September
- FDA Considers Mylan Application for Copaxone Generic Tuesday 15 September
- Myriad's Novel HIV Inhibitor Shows Strong Potential Tuesday 15 September
- Ariad to Continue Experimental Cancer Drug Study Tuesday 15 September
- Biocon and Amylin Collaborate on Novel Diabetes Therapy Monday 14 September
- Takeda Advances New Prostate Drug to Phase II Monday 14 September
- Adamas Triple Combo Antiviral Shows Swine Flu Potency Monday 14 September
- New Data for Eli Lilly's Cymbalta Shows Sustained Pain Relief Monday 14 September
- Ascenta Gets FDA Go-Ahead to Begin Cancer Antagonist Trials Friday 11 September
- Par Pharma to Begin Marketing Starlix Generic Friday 11 September
- Swiss Biotechs Arpida and Evolva Plan Merger Friday 11 September
- Galapagos Takes New Arthritis Candidate to Next Trial Phase Friday 11 September
- FDA Committee Backs Cervarix Cervical Cancer Vaccine Thursday 10 September
- EU Approves Januvia as Top Treatment for Type 2 Diabetes Thursday 10 September
- Anadys Begins Phase II Trials on Fast-Tracked Hepatitis C Treatment Thursday 10 September
- GPSI Targets India for New Drug Development Thursday 10 September
- Rheumatoid Arthritis Patients Taking Enbrel Work for Longer, Study Says Wednesday 09 September
- NICE Rejects Bayer's Nexavar as Liver Cancer Treatment Wednesday 09 September
- ISTA Gets FDA Approval for Bepreve Eye Drop Treatment Wednesday 09 September
- Protalix's prGCD Gets FDA Orphan Drug Designation Wednesday 09 September
- Sanofi Pasteur and Butantan to Provide Flu Vaccine to Brazil Tuesday 08 September
- Ark to Begin Studies on Innovative Foetal Growth Restriction Treatment Tuesday 08 September
- FDA Sets date for Pixantrone Decision Tuesday 08 September
- Debiopharm to License Ipsen's Cancer Inhibitor Tuesday 08 September
- Baxter Acquires Edwards Haemofiltration Business Monday 07 September
- Bristol-Myers Squibb Gets Go-Ahead for Belatacept Application Monday 07 September
- UK Swine Flu Fatality Threat Subsides Friday 04 September
- New Hope for HIV Prevention as Researchers Target Weak Spot Friday 04 September
- Novartis Swine Flu Vaccine Does Well in Pilot Trials Thursday 03 September
- Breakthrough Leukaemia Treatment Approved in Europe Thursday 03 September
- Stemedica to Manufacture Stem Cells in California Wednesday 02 September
- First Test Kit Launched for Tamiflu-Resistant Swine Flu Wednesday 02 September
- New Data Shows Slower Heart Rate Reduces Risk of Attacks Wednesday 02 September
- Bristol-Myers Squibb Completes Medarex Acquisition Wednesday 02 September
- FDA Approves Six New Versions of Heparin Tuesday 01 September
- Catalyst Licenses Northwestern University’s Novel Neurological Therapies Tuesday 01 September
- Watson Receives FDA Approval for Plan B Generic Tuesday 01 September
- AstraZeneca's New Heart Drug Ticagrelor Does Well in Trials Tuesday 01 September
- Mylan Begins Marketing BenzaClin Acne Generic Friday 28 August
- Bioo to Test Melamine Contamination in Pharmaceuticals Friday 28 August
- UCB and Immunomedics Announce Good Results in Landmark Lupus Study Friday 28 August
- Abbott and Pfizer to Use Genetic Test in Race to Cure Lung Cancer Friday 28 August
- New Bowel Therapy Extracted from Genetically Engineered Bacteria Thursday 27 August
- Wyeth Blasts NICE Kidney Cancer Drug Rejection Thursday 27 August
- Endo and ProStrakan Partner to Deliver New Testosterone Therapy Thursday 27 August
- Nymox Lead Drug Shows Positive Effects on Liver Cancer Thursday 27 August
- US Authorises Emergency H1N1 Test for Overseas Troops Wednesday 26 August
- UK Gives Thumbs Up to Alitretinoin Hand Eczema Treatment Wednesday 26 August
- Warner Chilcott Swoops for P&G's Pharmaceuticals Business Wednesday 26 August
- Profectus Enters Research Collaboration to Find Malaria Vaccine Wednesday 26 August
- FDA to Examine Dangers of Weight Loss Drug Orlistat Tuesday 25 August
- Xyzal Approved as Childhood Allergy Treatment in the US Tuesday 25 August
- UCB and Novartis Join Forces to Tap German Pharmaceutical Market Tuesday 25 August
- Discovery Shuttle Takes Vaccine Development to Space and Beyond Tuesday 25 August
- New Lymphoma Treatment Pixantrone Submitted for FDA Approval Monday 24 August
- First Infant Seizure Treatment Sabril Approved in the US Monday 24 August
- Takeda Reacquires Rights to Actos in Canada Monday 24 August
- Novartis Childhood Asthma Drug Xolair Approved in EU Monday 24 August
- FDA Warns Illegal Ibuprofen Marketers Friday 21 August
- Merck Wins Patent Infringement Lawsuit Against Teva Friday 21 August
- China Installs New Drug Policy to Boost Competition Friday 21 August
- Health Canada Approves Anika’s Monovisc Osteoarthritis Treatment Friday 21 August
- FDA Approves Hiberix as Children's Booster Hib Vaccine Thursday 20 August
- Adamas and US Navy Partner to Test Novel Flu Therapies Thursday 20 August
- Forest COPD Drug Oglemilast Fails to Impress in Trials Thursday 20 August
- China’s Zheiiang Orders Equipment for Oncology Medicines Thursday 20 August
- Eli Lilly Terminates Osteoporosis Drug Development Wednesday 19 August
- Genmab and GSK Blood Cancer Drug Trials Disappoint Wednesday 19 August
- Novavax Flu Virus Vaccine Reports Positive Preclinical Results Wednesday 19 August
- Study Shows Significant Risk of Heart Failure with Avandia Wednesday 19 August
- FDA Approves New MS Treatment Extavia Tuesday 18 August
- GSK and Brazil’s Fiocruz Partner for Vaccine Research Tuesday 18 August
- NeuroSearch and Janssen Form CNS Drug Discovery Alliance Tuesday 18 August
- Amgen's Vectibix Shows Strong Results in Colorectal Cancer Trials Tuesday 18 August
- FDA Advisory Gives Mixed Verdict on Amgen's Prolia Monday 17 August
- GSK Begins First Swine Flu Vaccine Study Monday 17 August
- US Regulators Approve Saphris Antipsychotic Monday 17 August
- US Inspectors Demand Info on Gilead Sciences' Ranexa Monday 17 August
- FDA Approves First Long-Acting Pain Opioid Embeda Friday 14 August
- OncoGenex Kicks off Solid Tumour Treatment Trials Friday 14 August
- Dynavax Pushes Hepatitis B Vaccine Development in Europe Friday 14 August
- Cannabis Science to develop Novel Swine Flu Treatment Friday 14 August
- FDA Clarifies Expanded Access to Investigational Drugs Thursday 13 August
- MSD's Isentress Compares Favourably with First-Line HIV Medications Thursday 13 August
- Sanofi-Aventis Heart Drug Approved in Canada Thursday 13 August
- Cryo-Cell and S-Evans Bioscience Combine to Research Menstrual Stem Cell Technology Thursday 13 August
- FDA Gives Tentative Approval for HIV Generic Wednesday 12 August
- Cephalon Enters Biologics Arena with Arana Acquisition Wednesday 12 August
- Amgen Announces Success in Two Pivotal Osteoporosis Studies Wednesday 12 August
- AstraZeneca and Forest Combine to Battle Antibiotic Resistance Wednesday 12 August
- Flu Drugs Less Effective in Children According to UK Research Tuesday 11 August
- US Approves Generic Version of GSK’s Imitrex Migraine Treatment Tuesday 11 August
- Nycomed and Forest Combine on Promising COPD Treatment Tuesday 11 August
- Inovio and NIH Centre Team Up to Advance Flu Vaccine Tuesday 11 August
- Novartis to Develop Opexa Stem Cell Technology Monday 10 August
- Merck Shareholders Back Schering-Plough Merger Monday 10 August
- Extra-Strength Ventavis Heart Drug gets FDA Approval Monday 10 August
- New Galapagos Arthritis Drug Tests Positively in Human Trials Monday 10 August
- FDA Instructs Pharma Companies to Watch for Melamine Friday 07 August
- Vectibix for Colorectal Cancer Shows Remarkable Survival Rates Friday 07 August
- NicOx Reacquires Rights to Pfizer Glaucoma Drug Friday 07 August
- EU Approves Afinitor for Use Against Advanced Renal Cancer Friday 07 August
- Largest-Ever Lung Cancer Trial Builds New Hope for Cures Thursday 06 August
- New Heart Attack Treatment Effient Now Available in US Thursday 06 August
- Genzyme Receives EU Approval for Blood Cancer Treatment Mozobil Thursday 06 August
- EpiCept Applies for Ceplene Approval In Canada Thursday 06 August
- US Warns Against Cancer Threat from TNF Blockers Wednesday 05 August
- GSK Announces New Orders for Flu Vaccine Wednesday 05 August
- Novartis Begins Shipping of Seasonal Flu Vaccine Ahead of Schedule Wednesday 05 August
- New Leukaemia Drug Trial Data Reveals Remarkable Results Wednesday 05 August
- New Cholesterol-Lowering Drug Approved in the US Tuesday 04 August
- Project Zero Delay Speeds Up Clinical Trials Tuesday 04 August
- Breakthrough into Malaria Origin Springs New Hope for Cures Tuesday 04 August
- Avastin Kidney Cancer Treatment Approved in US Tuesday 04 August
- New Type 2 Diabetes Treatment Gets FDA Go-Ahead Monday 03 August
- Very First Schizoaffective Disorder Treatment Approved Monday 03 August
- US Seizes Clarcon Skin Products Monday 03 August
- Phase III Tarceva Trial Shows Positive Survival Rates Monday 03 August
- Colchicine gets FDA Stamp of Approval Friday 31 July
- GSK and Genmab Announce Positive Arthritis Drug Trial Results Friday 31 July
- Sanofi-Aventis to acquire Merck's Share of Merial in $4bn Deal Friday 31 July
- Anadys Gets Go-Ahead for Hepatitis C Drug Trials Friday 31 July
- US Initiates Nationwide Recall of Steam Dietary Supplement Thursday 30 July
- Abbott Strengthens Nutritional Business in India Thursday 30 July
- Inovio Flu Vaccine Scores 100% in Animal Trials Thursday 30 July
- Watson Claims Marketing Rights to New Anaemia Generic in US Thursday 30 July
- FDA Warns Body Builders Against Steroid-Containing Supplements Wednesday 29 July
- New Patient-Specific Melanoma Vaccine Study Shows Long-Term Success Wednesday 29 July
- Britain Urges Elderly to Review Medicine Prescriptions Wednesday 29 July
- Promising Heart Drug Multaq Now Available in US Wednesday 29 July
- US Awards Emergency Authorisation for Additional H1N1 Flu Test Tuesday 28 July
- Wyeth Reports Breakthrough in Menopause Treatment Tuesday 28 July
- Takeda Submits NDA for Actos Combo in Japan Tuesday 28 July
- Amgen and GSK Combine to Commercialise Denosumab Tuesday 28 July
- Schering-Plough's Saphiris Meets Endpoints in Schizophrenia Trials Monday 27 July
- Landmark CAPS Treatment Ilaris set for European Approval Monday 27 July
- New Drug Traceability Tool Launched in Europe Monday 27 July
- Sanofi-Aventis Strengthens Vaccine Footprint in India Monday 27 July
- Merck Serono Submits Cladribine for European Authorisation Friday 24 July
- Lilly's Forteo Receives FDA Approval for Osteoporosis Friday 24 July
- Alcon and AstraZeneca Eye Partnership to Treat Ocular Illness Friday 24 July
- Bristol-Myers Squibb Reports Excellent Second Quarter Following Medarex Acquisition Friday 24 July
- UK Recommends Rituximab as First-Line Treatment for Chronic Leukaemia Thursday 23 July
- GSK and Enigma to Develop Rapid Flu Test Thursday 23 July
- Landmark African HIV Study Shows Remarkable Survival Rates Thursday 23 July
- Bayer and Onyx Announce Positive Breast Cancer Study Results Thursday 23 July
- Heptax Shows Promise Against Metabolic Syndrome Wednesday 22 July
- FDA Fast Tracks Apaziquone for Bladder Cancer Wednesday 22 July
- Exenatide Outperforms Lantus in Head-to-Head Study Wednesday 22 July
- Tekturna Approved as Alternative to Multiple Blood Pressure Drugs Wednesday 22 July
- Genentech’s Xelox Combo Shown to Extend Life in Colon Cancer Patients Tuesday 21 July
- Mylan Receives Additional Strength Approval for Antipsychotic Haloperidol Tuesday 21 July
- Human Genome Sciences Announces First Lupus Breakthrough in a Decade Tuesday 21 July
- Wyeth Shareholders Give Seal of Approval for Pfizer Takeover Tuesday 21 July
- Pfizer Receives EU Approval for Wyeth Acquisition Monday 20 July
- Swine Flu Virus Provides Slim Pickings for Vaccine, says Novartis Monday 20 July
- Tibotec and Gilead Combine to Develop New Antiretroviral Monday 20 July
- FDA Approves New Cancer BTP Drug Onsolis Monday 20 July
- France Enlists Sanofi Pasteur to Provide Flu Vaccine Friday 17 July
- Fera Acquires Rights to Seven Fougera Ophthalmic Drug Applications Friday 17 July
- Novartis Positive Despite 12% Decline in First Half Friday 17 July
- QI Begins Breast Cancer Immunotherapy Trials Friday 17 July
- US Drug Companies Settle with States Over Vytorin Marketing Thursday 16 July
- ADVTX Presents New Drug to Protect Against Nuclear Fall-Out Thursday 16 July
- Pfizer's New Alzheimer's Compounds Pass Phase I Testing Thursday 16 July
- TheraCell Grabs Israeli University's Novel Stem Cell Technologies Thursday 16 July
- Japan's Hisamitsu to Buy Noven Pharmaceuticals Wednesday 15 July
- New Tarceva Study Shows Advanced Survivability in Lung Cancer Patients Wednesday 15 July
- GSK Announces New Strategy to Fight HIV/AIDS in Sub-Saharan Africa Wednesday 15 July
- UK Launches New Blueprint to Fast-Track Innovative Pharmaceuticals Wednesday 15 July
- Teva's One-Step Emergency Contraceptive gets FDA Approval Tuesday 14 July
- US Senate Moves to Protect Biotech Drugs Tuesday 14 July
- Inovio's H1N1 Vaccine Shows Positive Response in Testing Tuesday 14 July
- J&J Completes Deal for Cougar Biotech Tuesday 14 July
- EpiCept Initiates Post-Approval Clinical Study with Ceplene Monday 13 July
- InNexus Partners with Genhelix for New Product Development Monday 13 July
- Addex Achieves Second Milestone In Parkinson's Disease Monday 13 July
- Bioniche and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin Monday 13 July
- Amarin Reaches Special Trials Agreement With FDA Friday 10 July
- Amylin Weight Loss Drug Shows Positive Results Friday 10 July
- Astrazeneca Terminates Map Pharma Licence Agreement Friday 10 July
- Merck and Portola to Co-Promote New Cardiovascular Drug Friday 10 July
- Alnylam to Share in GSK Tropical Diseases Patent Pool Thursday 09 July
- AstraZeneca to Press Forward on ADHD and Alzheimer's Drug Research Thursday 09 July
- GSK's Cervarix Proves Effective Against Cervical Cancer in Trials Thursday 09 July
- Novartis' Rasilez to be Available in Japan Thursday 09 July
- CanBas and Takeda Cancer Drug Enters Phase II Trials Wednesday 08 July
- FDA Accepts Once-Weekly Exenatide for Review Wednesday 08 July
- Novartis Extends TB Drug Donation to Tanzania Wednesday 08 July
- US FDA Orders Warnings for Darvocet But No Ban Wednesday 08 July
- Caraco Axes Workforce Following FDA Seizure Tuesday 07 July
- EU Commission Approves Viramune Tuesday 07 July
- FDA Outlines Future for TroVax Cancer Drug Tuesday 07 July
- Ikaria Agrees Exclusive Drug License with Bioline Tuesday 07 July
- Novo Nordisk Gets EU Nod to Market Diabetes Drug Victoza Monday 06 July
- New Deep Vein Thrombosis Drug Moves to Phase II Testing Monday 06 July
- Lundbeck Depressive Disorder Treatment Performs Well in Trials Monday 06 July
- Eisai Begins Trials on Paediatric Leukaemia Drug Dacogen Monday 06 July
- Bayer Files Patent Infringement Lawsuit Against Teva Friday 03 July
- Dow Streamline Sees Closure of Some Manufacturing Assets Friday 03 July
- FDA Approves Sanofi-Aventis Heart Drug Friday 03 July
- J&J and Elan Join Forces on Alzheimer's Immunotherapy Program Friday 03 July
- Vical H1N1 Flu Vaccine Scores 100% in Preclinical Trials Thursday 02 July
- Teva Oral Contraceptive Gets FDA Nod Thursday 02 July
- Spain Signs Up for Novavax Flu Vaccine Technology Thursday 02 July
- AstraZeneca Receives European Authorisation for IRESSA Cancer Drug Thursday 02 July
- Rexahn and Partner Co Combine to Research New Anti-Cancer Compound Wednesday 01 July
- FDA Finally Approves AMAG's Anaemia Treatment Wednesday 01 July
- Indian Pharmaceutical Company Takes SA Treasury to Court Wednesday 01 July
- Mylan and Biocon Announce Collaboration Wednesday 01 July
- Swine Flu Shows Resistance to Tamiflu in Denmark Tuesday 30 June
- Bayer Schering Signs Cancer Therapeutics Agreement with Celera Tuesday 30 June
- BiovaxID Now Available In Europe Tuesday 30 June
- Zebinix Anti-Epileptic Shows Long-Term Success Tuesday 30 June
- Antigenics Expands Phase II Glioma Trial Monday 29 June
- Inotek Sees Positive Results for Glaucoma Drug Study Monday 29 June
- Sun Pharma Shares Plunge After US Authorities Seize Drugs Monday 29 June
- Takeda's New Diabetes Drug Fails to Gain US Approval Monday 29 June
- Global Pharmaceutical Packaging predicted to rise 5.3% a year Friday 26 June
- ImmunoCellular and Formatech Join Forces on Cancer Stem Cell Vaccine Friday 26 June
- Novartis Afinitor Combo Shows Good Results Friday 26 June
- Sandoz Receives Authorisation for Japanese Somatropin Friday 26 June
- Teva Begins Phase III Trials for MS Drug Laquinimod Friday 26 June
- Cell Therapeutics Submits NDA for Pixantrone Lymphoma Drug Thursday 25 June
- Javelin Completes Safety Study Of Dyloject Pain Drug Thursday 25 June
- Last Moment Launch for Finasteride in France Thursday 25 June
- New Zealand Government Authorises Diabecell Diabetes Drug Trials Thursday 25 June
- Cordex Signs European Partnership for ATPotent Wednesday 24 June
- Cytopia Files Application for New Myelofibrosis Inhibitor Wednesday 24 June
- Daiichi-Sankyo Initiates Phase II Lung Cancer Trials Wednesday 24 June
- GSK Forms Alliance with Chroma Therapeutics Wednesday 24 June
- US Pharmaceutical Companies Agree to Cut Drug Costs for Seniors Tuesday 23 June
- Merck KGaA Initiates Advanced Study on Breast Cancer Drug Tuesday 23 June
- BioLineRx Antipsychotic Drug Shows Good Results Tuesday 23 June
- NeurogesX and Astellas to Market Qutenza in Europe Tuesday 23 June
- GeoVax Signs Proposal to Accelerate HIV/AIDS Vaccine Monday 22 June
- The Medicines Company Awarded Exclusivity on Angiomax Monday 22 June
- US Court Rules in Favour of Hospira Eloxatin Generic Monday 22 June
- Vical sees Progress on RapidResponse DNA Vaccine Platform Monday 22 June
- FDA Approves First-of-its-Kind OZURDEX Friday 19 June
- AMT Pancreatitis Drug Shows Benefits After One Administration Friday 19 June
- Novartis Ilaris Drug Gets Go ahead Friday 19 June
- Antares Pharma LibiGel Safety Study Encouraging Friday 19 June
- Watson Pharmaceuticals to Acquire Arrow Group Thursday 18 June
- BioAlliance Submits Loramyc NDA to FDA Thursday 18 June
- Sanofi-Aventis Donates Flu Vaccine to WHO Thursday 18 June
- J&J and Shire Win Exclusivity Case on Alzheimer’s Drug Thursday 18 June
- FDA Accepts OSI's Tacerva Lung Cancer Drug for Review Wednesday 17 June
- Pluristem Granted Permission in EU to Trial Stem Cell Product Wednesday 17 June
- GSK's Azerra Review Extended Wednesday 17 June
- Boehringer Ingelheim and Vitae Collaborate on Novel Alzheimer's Treatments Wednesday 17 June
- Euro Commission Approves Genzyme Kidney Drug Renvela Tuesday 16 June
- All Elesclomol Rights Returned to Synta Tuesday 16 June
- GSK and Dr Reddy’s Strike Emerging Market Alliance Tuesday 16 June
- Eli Lilly Launches Initiative to Find New Drugs Tuesday 16 June
- Merck Sorono Agrees Deals to Co-Develop Erbitux in Japan Monday 15 June
- Novartis Swine Flu Vaccine Ready for Testing Monday 15 June
- Sanofi Pasteur Ready to Tackle Flu Pandemic Monday 15 June
- VIA and FDA Meet on Cardiovascular Drug Monday 15 June
- FDA Votes Zyprexa Safe for Teens Friday 12 June
- Emergent’s BioThrax Anthrax Vaccine Gets Longer Shelf Life Friday 12 June
- Study Supports Mirapexin and Sifrol for Parkinsons Disease Friday 12 June
- Alexion's Soliris Wins Prix Galien Award Friday 12 June
- Arete Diabetes Inhibitor Shows Positive Clinical Results Thursday 11 June
- CEL-SCI Uses LEAPS Technology to Test H1N1 Flu Strain Thursday 11 June
- Pharmasset Hepatitis C Trials Move Forward Thursday 11 June
- Roche’s Actemra Shows High Remission Rates for Arthritis Thursday 11 June
- Swine Flu Officially Declared a Pandemic Thursday 11 June
- PDX and Rx Seek Online Prescription Collaboration with Microsoft Wednesday 10 June
- GSK and Shenzhen Collaborate to Develop Flu Vaccines for China Wednesday 10 June
- ICON To Manage Eli Lilly European Clinical Trials Wednesday 10 June
- Raptor and Roche Collaboration Seeks to Cross Blood-Brain Barrier Wednesday 10 June
- GSK’s Rotarix Vaccine Given Global WHO Prequalification Tuesday 09 June
- Active Biotech's Prostate Cancer Drug Enters Phase II Trials Tuesday 09 June
- Novartis Lymphoma Drug Shows Significant Tumour Reduction Tuesday 09 June
- Once-Weekly Exenatide Shows Encouraging Diabetes Results Tuesday 09 June
- Integrated SAP Solutions for Pharmaceutical Packaging Tuesday 09 June
- New Pharmaceutical Market World Order to Rise by 2013 Monday 08 June
- Merck's Heart Drug Rolofylline Fails Trials Monday 08 June
- Novartis' Tasigna Leukaemia Treatment Tests Positive Monday 08 June
- Novo Nordisk’s Diabetes Monotherapy Shown to Reduce Blood Sugar Monday 08 June
- Amgen’s Nplate Shown to Reduce ITP Patient Bleeding Monday 08 June
- Wyeth's Enbrel Gets European Thumbs Up Friday 05 June
- EpiCept's Ceplene Proves Positive Against Leukaemia Relapse Friday 05 June
- Novartis to Develop Typhoid Fever Vaccine Friday 05 June
- Novel Novavax Vaccine to be Evaluated for Flu Virus Friday 05 June
- Bayer and Genzyme Strike New Strategic Alliance Thursday 04 June
- Delcath Wins Orphan Designation for Tumour Drug Thursday 04 June
- Arbor Unveils New ‘Swimmer's Ear’ Treatment Thursday 04 June
- PolyMedix to Research Anti-Biowarfare Pathogens Thursday 04 June
- MedImmune Lands Swine Flu Vaccine contract from US Health Dept Wednesday 03 June
- AstraZeneca and Merck Team Up for Cancer Clinical Trials Wednesday 03 June
- GSK Epilepsy Treatment Gets FDA Approval Wednesday 03 June
- FDA Calls for More Trials on ARCA’s Gencaro Heart Drug Wednesday 03 June
- Phase III Study Reveals Positive Results For Crohn's Drug Tuesday 02 June
- Immunomedics' Targeted Radiation Therapy Combo Trials Positive Tuesday 02 June
- Lilly's Gemzar shows Positive Results for Cervical Cancer Tuesday 02 June
- Roche Study Offers New Hope for Lung Cancer Sufferers Tuesday 02 June
- Pfizer Announces Positive Lung Cancer Trial Results Monday 01 June
- Catalyst Pharmaceuticals Sees Light for Cocaine Treatment Monday 01 June
- GSK's Arzerra Wins FDA Recommendation Monday 01 June
- Mylan’s Singulair Generic gets Tentative Approval Monday 01 June
- Novartis Ups Bid For Novartis India Friday 29 May
- Sanofi-Aventis and Exelixis Sign Exclusive Oncology Collaboration Friday 29 May
- NICE Recommends Pfizer Sutent Tumour Treatment Friday 29 May
- Bayer Initiates Phase III Trial for Liver Cancer Drug Friday 29 May
- Amgen Claims Rights to Experimental Heart Drug Thursday 28 May
- Stelara Review Timeline Extended by FDA Thursday 28 May
- Astella to Launch Eczema Ointment in Europe Thursday 28 May
- Naproxen Prodrug Clinical Results Positive Thursday 28 May
- FDA Issues Drug Advert Guidelines Wednesday 27 May
- US Health Department Purchases GSK Swine Flu Vaccine Wednesday 27 May
- Alcon Launches First Singapore Manufacturing Plant Wednesday 27 May
- Antipodean Pharmaceuticals Initiates Phase II Trial For Parkinson's Disease Wednesday 27 May
- Roche's Phase III Actemra Study Achieves Goal Tuesday 26 May
- US FDA Puts Aastrom Trial on Hold Pending Investigation Tuesday 26 May
- Eli Lilly Launches Global Alzheimer's Drug Trials Tuesday 26 May
- Johnson & Johnson Confirm $1bn Cougar Biotech Offer Tuesday 26 May
- Australia Requires TGA Certificate for Products with Drug Component Friday 22 May
- Moksha8 and Roche Expand Brazilian and Mexican Market Alliance Friday 22 May
- Cholesterol Drug Mipomersen Trial Shows Positive Results Friday 22 May
- Japan Sees Strong Challenge from Generic Drugs Friday 22 May
- Solvay Licenses Drug Rights From Lipocine Thursday 21 May
- Cancer Research UK and GSK to Join Forces on Cancer Drug Thursday 21 May
- Elixir and Novartis Enter into Option Agreement Thursday 21 May
- FDA Fast-Tracks Enobia's Enzyme Replacement Therapy Thursday 21 May
- Pre-Clinical Study Reveals Light-Activated Drug Therapy to Treat Cancer Wednesday 20 May
- India’s Drug Makers Seek Product Line Licence Change Wednesday 20 May
- Biovail Acquires Worldwide Drug Rights to Tetrabenazine Wednesday 20 May
- EU Awards €246m to Drug R&D Projects Wednesday 20 May
- Algeria Prohibits Drug Imports in Bid to Boost Local Industry Tuesday 19 May
- Botox Rival Dysport Gets FDA Approval Tuesday 19 May
- Glaxo and Oxford form Cancer Research Alliance Tuesday 19 May
- NovImmune Raises $54.8m to Reclaim Lead Compounds Monday 18 May
- Osmetech Submits New Swine Flu test for Approval Monday 18 May
- PerkinElmer and BioLegend Form Assay Alliance Monday 18 May
- UCB Arthritis Drug Wins FDA Approval Monday 18 May
- New Swine Flu Test From Quest Diagnostics Friday 15 May
- Acucela Reports Encouraging Data on Dry AMD Therapy Friday 15 May
- GlaxoSmithKline Extends Collaboration with South Africa’s Aspen Friday 15 May
- Daiichi Sankyo Roadmap Study Shows Blood Pressure Reduction Friday 15 May
- UK Agrees Deal for Countrywide Flu Vaccine Friday 15 May
- WHO Investigating Claims that Swine Flu is Man Made Thursday 14 May
- UK Has Eight Swine Flu Cases, Helpline Set Up Thursday 30 April
- Pfizer and Medivation Initiate Alzheimer’s Investigational Drug Trials Monday 20 April
- Alexion Files Application for New Blood Disorder Drug Tuesday 07 April
- Altea to Develop Sustained Exenatide Transdermal Patch Tuesday 07 April
- US Doctors Pushed to End Pharma Ties Friday 03 April
- McKesson Launches Diagnostics Management Link Up Tool Friday 03 April
- Kardia to Launch Vascular Viewing System Friday 03 April
- Bristol Diabetes Pill Promising Says Advisory Panel Thursday 02 April
- EMERFLU Approved for Humans in Australia Wednesday 01 April
- Gilead Receives No Go on Cystic Fibrosis drug Thursday 26 March
- XTL Biopharmaceuticals Agrees Asset Purchase with Bio-GAL Tuesday 24 March
- Generic Drugs Hold Disintegration Risk Thursday 19 February
- Expect Stringent Temperature Legislation, Warn Pharma Cool Chain Experts Thursday 29 January
- Pharma Lead Times Place Stress on Packaging Producers Thursday 22 January
- Dishman Expands Asian Presence Thursday 02 October
- Risk of Product Degradation by Lack of Pharma Planning Wednesday 01 October
- Maggots Highlight Global Regulatory Discrepancies Wednesday 01 October
- Pharma Industry Faces Poor Solubility Challenge Wednesday 01 October
- SCM Diversifies Product Range Wednesday 01 October
- Cephalon Settles Federal and State Investigations Monday 29 September
- GTx Says Muscle Drug Holds Promise Wednesday 03 September
- Online Fraud Hits Pharmaceutical Brands Tuesday 02 September
- Israeli Pharmaceutical Industry's EU Trade Boost Wednesday 20 August
- Drug Firms Deny National Institute Claims of Over Pricing Monday 18 August
